Bayer and Biogen announced they were both adopting .med TLDs on August 12, 2025.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bayer and Biogen announced they were both adopting .med TLDs on August 12, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Biogen and Marker Therapeutics are two healthcare companies that are currently competing for investment.
- Bayer secured Series B funding in a recent funding round involving Sabanto.
- Bayer presented research findings at a meeting held in Arizona on September 10, 2026.
- Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
- Bayer is conducting INERA trials spanning 100 acres in India and plans to distribute the product.
Coverage
Newest first; wire copies grouped- PR NewswireNew .med Domain Names Surpass 40,000 Pre-Orders in July CLEVELAND, Aug. 12, 2025 /PRNewswire/ -- With consumers struggling to differentiate between credible and unreliable medical information online,